Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Staszewski

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
JAMA|November 28, 2001
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral loadA N Phillips, S Staszewski, R Weber, et al.
AIDS (London, England)|April 13, 1999
Virological response to protease inhibitor therapy in an HIV clinic cohortS Staszewski, V Miller, C Sabin, et al.
Journal of Medical Virology|November 20, 1997
Frequencies of GB virus C/hepatitis G virus genomes and of specific antibodies in German risk and non-risk populationsC M Nübling, H Bialleck, A J Fürsch, et al.
Deutsche Medizinische Wochenschrift (1946)|March 10, 1989
[HIV infection with a serological variant]R Enzensberger, H W Doerr, H von Briesen, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|January 1, 1995
Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups/Frankfurt a.M., GermanyB Weber, H Rabenau, A Berger, et al.
Clinical Trials (London, England)|June 16, 2006
The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) eraA Mocroft, J Neaton, J Bebchuk, et al.
HIV Medicine|November 21, 2008
Factors associated with viral rebound among highly treatment-experienced HIV-positive patients who have achieved viral suppressionC J Smith, A N Phillips, B Dauer, et al.
Antiviral Therapy|June 10, 2000
HIV drug susceptibility and treatment response to mega-HAART regimen in patients from the Frankfurt HIV cohortV Miller, A Cozzi-Lepri, K Hertogs, et al.
AIDS (London, England)|December 12, 2001
Durability of HIV-1 viral suppression over 3.3 years with multi-drug antiretroviral therapy in previously drug-naive individualsA N Phillips, V Miller, C Sabin, et al.
Haematologica|June 15, 2007
First case of successful allogeneic stem cell transplantation in an HIV-patient who acquired severe aplastic anemiaT Wolf, V Rickerts, S Staszewski, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
JAMA|November 28, 2001
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral loadA N Phillips, S Staszewski, R Weber, et al.
AIDS (London, England)|April 13, 1999
Virological response to protease inhibitor therapy in an HIV clinic cohortS Staszewski, V Miller, C Sabin, et al.
Journal of Medical Virology|November 20, 1997
Frequencies of GB virus C/hepatitis G virus genomes and of specific antibodies in German risk and non-risk populationsC M Nübling, H Bialleck, A J Fürsch, et al.
Deutsche Medizinische Wochenschrift (1946)|March 10, 1989
[HIV infection with a serological variant]R Enzensberger, H W Doerr, H von Briesen, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|January 1, 1995
Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups/Frankfurt a.M., GermanyB Weber, H Rabenau, A Berger, et al.
Clinical Trials (London, England)|June 16, 2006
The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) eraA Mocroft, J Neaton, J Bebchuk, et al.
HIV Medicine|November 21, 2008
Factors associated with viral rebound among highly treatment-experienced HIV-positive patients who have achieved viral suppressionC J Smith, A N Phillips, B Dauer, et al.
Antiviral Therapy|June 10, 2000
HIV drug susceptibility and treatment response to mega-HAART regimen in patients from the Frankfurt HIV cohortV Miller, A Cozzi-Lepri, K Hertogs, et al.
AIDS (London, England)|December 12, 2001
Durability of HIV-1 viral suppression over 3.3 years with multi-drug antiretroviral therapy in previously drug-naive individualsA N Phillips, V Miller, C Sabin, et al.
Haematologica|June 15, 2007
First case of successful allogeneic stem cell transplantation in an HIV-patient who acquired severe aplastic anemiaT Wolf, V Rickerts, S Staszewski, et al.
Pageof 10